ReviewDrug design, development and therapy2017

Comparison of efficacy and safety of oral agents for the treatment of relapsing-remitting multiple sclerosis.

Cristina Guarnera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.